200 related articles for article (PubMed ID: 7684850)
1. [Should inoperable pulmonary cancer be treated?].
Klastersky J
Rev Med Brux; 1993 Apr; 14(4):102-9. PubMed ID: 7684850
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
[No Abstract] [Full Text] [Related]
4. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
5. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of non-small cell lung carcinoma].
van Zandwijk N; Letschert JG; Zoetmulder FA; McVie JG
Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1338-42. PubMed ID: 2457818
[No Abstract] [Full Text] [Related]
7. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Papadakis E
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
[No Abstract] [Full Text] [Related]
9. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
11. [Combined modality treatment of lung cancer: present and future].
Ohta M; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1186-91. PubMed ID: 3031350
[No Abstract] [Full Text] [Related]
12. New advances in the treatment of locally advanced non-small cell lung cancer and breast cancer.
Chang AY
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():233-7. PubMed ID: 10895159
[No Abstract] [Full Text] [Related]
13. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
Weitberg AB; Liu L; Yashar J; Glicksman AS
J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
[TBL] [Abstract][Full Text] [Related]
15. How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
Kunitoh H; Suzuki K
Br J Cancer; 2007 May; 96(10):1498-503. PubMed ID: 17473830
[TBL] [Abstract][Full Text] [Related]
16. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
[No Abstract] [Full Text] [Related]
17. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy and chemotherapy for locally advanced non-small-cell lung cancer: report of a clinical trial and review of the literature. South Osaka Lung Cancer Chemotherapy Study Group].
Kawahara M; Kubota K; Furuse K
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():212-7. PubMed ID: 8007468
[TBL] [Abstract][Full Text] [Related]
19. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
Watanabe Y
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
[TBL] [Abstract][Full Text] [Related]
20. Induction chemoradiotherapy followed by surgery for stage III non-small cell lung cancer.
Yoneda S; Yamamoto M; Sakura M; Izumo T; Noguchi Y; Nishimura H; Sakai H; Gotoh I; Kobayashi K; Hayashi K
Jpn J Clin Oncol; 1993 Jun; 23(3):173-7. PubMed ID: 8394472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
